deltatrials
Active Not Recruiting PHASE2 INTERVENTIONAL 2-arm NCT02817958

Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis (MEGACEP)

Prospective Phase II Study Evaluating a Multimodal Care of Inguinal Node Metastasis in Squamous Cell Carcinoma of the Penis by Bilateral Lymphadenectomy and Chemotherapy TIP

Sponsor: National Cancer Institute, France

Conditions Penile Cancer Squamous Carcinoma
Interventions Chemotherapy TIP
Updated 16 times since 2017 Last updated: Jun 21, 2025 Started: Oct 17, 2016 Primary completion: Sep 30, 2026 Completion: Sep 30, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Penile Cancer and Squamous Carcinoma, this trial is ongoing. The trial is conducted by National Cancer Institute, France and has accumulated 16 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Nov 2017 · 10 months · monthly snapshot~Nov 2017 – ~Feb 2018 · 3 months · monthly snapshot~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshot~Jun 2018 – ~Apr 2019 · 10 months · monthly snapshot~Apr 2019 – ~May 2020 · 13 months · monthly snapshot~May 2020 – ~Oct 2020 · 5 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshot~Oct 2021 – ~Nov 2022 · 13 months · monthly snapshot~Nov 2022 – ~Dec 2023 · 13 months · monthly snapshot~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshot~Jan 2025 – ~Jul 2025 · 6 months · monthly snapshot~Jul 2025 – ~Sep 2025 · 2 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

16 versions recorded

  1. Sep 2025 — Present [monthly]

    Active Not Recruiting PHASE2

  2. Jul 2025 — Sep 2025 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  3. Jan 2025 — Jul 2025 [monthly]

    Recruiting PHASE2

  4. Sep 2024 — Jan 2025 [monthly]

    Recruiting PHASE2

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

▶ Show 11 earlier versions

  1. Dec 2023 — Jul 2024 [monthly]

    Recruiting PHASE2

  2. Nov 2022 — Dec 2023 [monthly]

    Recruiting PHASE2

  3. Oct 2021 — Nov 2022 [monthly]

    Recruiting PHASE2

  4. Jan 2021 — Oct 2021 [monthly]

    Recruiting PHASE2

  5. Oct 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

    Status: Suspended → Recruiting

  6. May 2020 — Oct 2020 [monthly]

    Suspended PHASE2

    Status: Recruiting → Suspended

  7. Apr 2019 — May 2020 [monthly]

    Recruiting PHASE2

  8. Jun 2018 — Apr 2019 [monthly]

    Recruiting PHASE2

  9. Feb 2018 — Jun 2018 [monthly]

    Recruiting PHASE2

  10. Nov 2017 — Feb 2018 [monthly]

    Recruiting PHASE2

    Status: Active Not Recruiting → Recruiting

  11. Jan 2017 — Nov 2017 [monthly]

    Active Not Recruiting PHASE2

    First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute, France
  • UNICANCER
Data source: UNICANCER

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Angers, France , Besançon, France , Bordeaux, France , Caen, France , Clermont-Ferrand, France , Limoges, France , Lyon, France , Marseille, France , Nancy, France , Nantes, France and 6 more locations